Curcumin-docetaxel co-loaded nanosuspension for enhanced anti-breast cancer activity

The in vitro and in vivo study of the nanosuspensions has shown that Co-administration of Curcumin as a p-gp inhibitor with docetaxel may have the potential to increase the anti-breast cancer efficacy of both drugs.